Dr. Benjamin Chien founded Quest Pharmaceutical Services in 1995 as a single-site CRO focused on bioanalysis services. In 2008, Dr. Chien was the recipient of the 2008 Delaware Bioscience Association Service Award in recognition of his multi-year contributions and financial support to the development of bioscience in Delaware. In 2013, QPS received Company of The Year Award from Delaware Bioscience Association in recognition of QPS impressive growth globally. Dr. Chien also serves on the board of a number of non-profit organizations. Dr. Chien began his pharmaceutical career at DuPont Merck Pharmaceutical Co. in the Drug Metabolism and Pharmacokinetics Section where he built the LC-MS/MS group. While at DuPont Merck, he received the Summit Award for his contribution to the development of Sustiva®, an anti-viral drug approved by the FDA for the treatment of HIV. In addition, Dr. Chien is the co-inventor of a novel Ion Trap/Time-of-Flight Mass Spectrometer. Dr. Chien obtained his Ph.D. in analytical chemistry (mass spectrometry) from the University of Michigan at Ann Arbor.  

 BioAnalysis, Molecular genomics